Cancer on chip: A step toward personalized, predictive and ethical cancer research

Read full text Summarise with VIRAT
Authors: Rudra Mhatre, Jyoti Sonawane, Chetana Mayekae, Diya J Mhaskar, Sherya Mumbaikar, Divya Monde
Cited by: 0
References: 89

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Metastasis accounts for nearly 90% of all cancer-related deaths, making cancer one of the leading causes of mortality worldwide. Although traditional preclinical models such as 2D cell cultures, 3D spheroids, organoids, and animal studies have advanced our understanding of cancer biology, they often fail to capture the full complexity of the human tumour microenvironment (TME). Organ-on-a-chip (OoC) technology has emerged as an innovative approach that integrates biology, engineering, and microfluidics to recreate real-time physiological and pathological processes at the organ level. Cancer-on-chip (CoC) systems, a subset of this technology, replicate key features of the TME—such as cellular diversity, fluid dynamics, and mechanical forces—to more accurately model tumour growth, metastasis, and drug responses. These systems have shown great promise in studying tumour biology, drug screening, treatment resistance, and metastasis, particularly in liver, lung, and breast cancers. By incorporating patient-derived cells, CoC platforms also open new opportunities for personalised medicine and for exploring how cancer interacts with the immune system. Despite their potential to revolutionise drug discovery and disease modelling, challenges such as standardisation, scalability, and clinical translation remain. Looking ahead, integrating organoids with OoC systems to create multi-organ or body-on-chip models could further enhance their ability to mimic human physiology. Overall, cancer-on-chip technology represents a powerful step toward more accurate, efficient, and personalised approaches in cancer research and therapy development.

Fields of Study & Subjects

3D Printing in Biomedical Research Microfluidic and Capillary Electrophoresis Applications Cancer Cells and Metastasis

Publication details

Journal / source
International Journal of Pharmacy and Pharmaceutical Science
Volume
8
Issue
2
Pages
54–63
Publication date
1 February 2026
Language
EN